Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Gilead Sciences Stories

2013-11-11 08:32:00

HONG KONG, Nov. 11, 2013 /PRNewswire/ -- US market investors can reveal the performance of company insiders from the insider trading reports. Today's reports will cover the following stocks: Facebook (NASDAQ:FB), Microsoft (NASDAQ:MSFT), Gilead Sciences (NASDAQ:GILD), Bank of America (NYSE:BAC), Riverbed (NASDAQ:RVBD), and Wells Fargo (NYSE:WFC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and...

2013-10-31 08:29:25

Top 50 CEOs delivered average return of 93.5% over three year period GREENWICH, Conn., Oct. 31, 2013 /PRNewswire/ -- Chief Executive magazine announced that Dun & Bradstreet CEO Sara Mathew has topped all S&P 500 peers to claim the title of Top Wealth Creator in 2013. The ranking shows who has created the most value for shareholders from July 2010 through June 2013. Mathew has astutely guided the 171-year-old provider of data and risk-management services at a time of challenging...

2013-10-30 08:32:46

CORAL SPRINGS, Florida, October 30, 2013 /PRNewswire/ -- Market news commentary and reports for sector leading nutrition, technology & pharma companies: Muscle Warfare International Inc. (OTC: MWAR), Baidu Inc (NASDAQ: BIDU), Herbalife Ltd. (NYSE: HLF), Gilead Sciences, Inc. (NASDAQ: GILD) and ARIAD Pharmaceuticals , Inc.(NASDAQ: ARIA). Muscle Warfare International Inc. (OTC: MWAR) releases investor information for 506 Capital Raise - Muscle Warfare International...

2013-10-29 23:21:37

Reportbuyer.com just published a new market research report: Drug Delivery Technologies: Commercial Prospects 2013-2023. London (PRWEB) October 29, 2013 Report Details Drug delivery technology - discover technological and commercial prospects What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions. Many commercial opportunities for improved drug delivery exist. You discover sales...

2013-10-24 23:20:07

Reportbuyer.com just published a new market research report: Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013. London (PRWEB) October 24, 2013 Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013" provides data on the Cytomegalovirus (HHV-5) Infections clinical trial scenario. This report provides elemental...

2013-10-22 12:29:36

LONDON, Oct. 22, 2013 /PRNewswire/ -- ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR) combining dolutegravir, abacavir and lamivudine for the treatment of people living with HIV-1. This New Drug Application (NDA) follows the approval of dolutegravir by the US Food and Drug Administration (FDA) in August 2013 under the brand name Tivicay(®), approved for use in combination with other...

2013-10-09 23:23:02

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) October 09, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The...

2013-10-08 08:28:32

SEATTLE, Oct. 8, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company with marketing applications for its lead product OMS302 for use during lens replacement surgery currently under review in both the US and Europe, today announced the appointment of Michael K. Inouye as vice president, commercial operations. Mr. Inouye has over 20 years of management experience in the pharmaceutical industry. His experience includes positions as...

2013-10-07 08:30:04

HONG KONG, Oct. 7, 2013 /PRNewswire/ -- US market investors can reveal the performance of company insiders from the insider trading reports. Today's reports will cover the following stocks: QUALCOMM (NASDAQ:QCOM), Gilead Sciences (NASDAQ:GILD), First Solar (NASDAQ:FSLR), Hertz (NYSE:HTZ), Forest Oil (NYSE:FST), and Corning (NYSE:GLW). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the...

2013-09-30 08:35:10

HONG KONG, Sept. 30, 2013 /PRNewswire/ -- US market investors can learn more about the performance of company insiders from the insider trading reports. Today's reports will cover the following stocks: QUALCOMM (NASDAQ:QCOM), Las Vegas Sands (NYSE:LVS), Gilead Sciences (NASDAQ:GILD), Microsoft (NASDAQ:MSFT), Yahoo! (NASDAQ:YHOO), and Bank of America (NYSE:BAC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may...